MX9504261A - Derivados de oxima, su preparacion y su uso terapeutico. - Google Patents

Derivados de oxima, su preparacion y su uso terapeutico.

Info

Publication number
MX9504261A
MX9504261A MX9504261A MX9504261A MX9504261A MX 9504261 A MX9504261 A MX 9504261A MX 9504261 A MX9504261 A MX 9504261A MX 9504261 A MX9504261 A MX 9504261A MX 9504261 A MX9504261 A MX 9504261A
Authority
MX
Mexico
Prior art keywords
group
hydrogen
substituted
formula
oxime derivatives
Prior art date
Application number
MX9504261A
Other languages
English (en)
Inventor
Hiroaki Yanagisawa
Takashi Fujita
Koichi Fujimoto
Takao Yoshioka
Kunio Wada
Minoru Oguchi
Toshihiko Fujiwara
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MX9504261A publication Critical patent/MX9504261A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Los compuestos de la formula (I); en donde: R1 es un hidrogeno o alquilo; R2 es alquileno; R3 es hidrogeno, alquilo, alcoxi, alquiltio, halogeno, grupo nitro, grupo amino, monoalquilamino, dialquilamino, arilo, o aralquilo; X es arilo, o heterocíclico aromático; Y es oxígeno, azufre o un grupo de la formula>N-R4n en la que R4 es hidrogeno, alquilo o acilo; y Z es un grupo de la formula (Za), (Zb), (Zc) o (Zd); y sales de los mismos pueden utilizarse para tratar o prevenir padecimientos que incluyen aquellos que surgen a partir de hiperlipidemia, hiperglicemia, obesidad, tolerancia a la glucosa deteriorada, resistencia a la insulina sin (IGT), tolerancia a la glucosa sin diagnostico, resistencia a la insulina, complicaciones diabéticas, hígado graso, síndrome de ovario policístico, (PCOS); y diabetes mellitus gestacional (GDM), además los compuestos de la presente invencion tienen actividad inhibidora de aldosa reductasa.
MX9504261A 1994-10-07 1995-10-06 Derivados de oxima, su preparacion y su uso terapeutico. MX9504261A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24387694 1994-10-07
JP13678895 1995-06-02

Publications (1)

Publication Number Publication Date
MX9504261A true MX9504261A (es) 1997-01-31

Family

ID=26470291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9504261A MX9504261A (es) 1994-10-07 1995-10-06 Derivados de oxima, su preparacion y su uso terapeutico.

Country Status (20)

Country Link
US (3) US5703096A (es)
EP (1) EP0708098B1 (es)
KR (1) KR100250175B1 (es)
CN (1) CN1056840C (es)
AT (1) ATE177088T1 (es)
AU (1) AU688573B2 (es)
CA (1) CA2159938A1 (es)
CZ (1) CZ261095A3 (es)
DE (1) DE69508029T2 (es)
DK (1) DK0708098T3 (es)
ES (1) ES2132536T3 (es)
FI (1) FI954763A7 (es)
GR (1) GR3030207T3 (es)
HU (1) HUT72642A (es)
IL (1) IL115536A (es)
MX (1) MX9504261A (es)
NO (1) NO305954B1 (es)
NZ (1) NZ280181A (es)
RU (1) RU2122998C1 (es)
TW (1) TW400329B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038427A1 (en) * 1995-06-02 1996-12-05 Sankyo Company, Limited Aromatic oxyimino derivatives
NO318765B1 (no) * 1995-07-03 2005-05-02 Sankyo Co Anvendelse av en HMG-CoA reduktaseinhibitor og en insulinsensibilisator til fremstilling av et medikament for forebyggelse eller behandling av arteriosklerose eller xantom, samt pakket farmasoytisk preparat som omfatter de to midlene i separate porsjoner.
EP0783888A1 (en) * 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
NZ332136A (en) * 1996-04-04 1999-08-30 Sankyo Co Phenylalkylcarboxylic acid derivatives useful for treating hyperglycemia
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
CA2257284C (en) * 1996-05-31 2005-10-04 Sankyo Company Limited Remedy for autoimmune diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
CA2258949C (en) 1996-07-01 2008-05-06 Dr. Reddy's Research Foundation Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
WO1998020871A1 (en) * 1996-11-08 1998-05-22 Nippon Chemiphar Co., Ltd. Visceral fat lowering agent
HUP9902721A2 (hu) * 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
US6019229A (en) * 1997-12-18 2000-02-01 Fleetguard, Inc. Self-centering, floating retainer for spin-on filter
WO1999058510A1 (en) 1998-05-11 1999-11-18 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
CA2369971A1 (en) * 1999-04-07 2000-10-19 Sankyo Company, Limited Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof
WO2001034579A1 (en) * 1999-11-10 2001-05-17 Takeda Chemical Industries, Ltd. Alkoxyiminoalkanoic acid derivatives
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
RU2374239C2 (ru) 2004-07-28 2009-11-27 Ф.Хоффманн-Ля Рош Аг Производные арилпиридина
CN115887434B (zh) * 2022-11-23 2024-12-24 四川大学 具有抗氧化作用的药物用于制备治疗多囊卵巢综合征药物的用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
FR2538388B1 (fr) * 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
EP0295828A1 (en) * 1987-06-13 1988-12-21 Beecham Group Plc Novel compounds
US4728739A (en) * 1987-06-15 1988-03-01 American Home Products Corporation Hypoglycemic thiazolidinediones
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
KR930701420A (ko) * 1990-08-23 1993-06-11 알렌 제이. 스피겔 혈당저하제로서의 하이드록시우레아 유도체
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023585D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5420146A (en) * 1994-05-10 1995-05-30 American Home Products Corporation Di-oxadiazolidine derivatives as antihyperglycemic agents
JPH08143556A (ja) * 1994-11-15 1996-06-04 Terumo Corp ジオキソチアゾリジン誘導体及びそれを含有する医薬組成物
JPH08143568A (ja) * 1994-11-22 1996-06-04 Terumo Corp ピリドピリミジン誘導体及びそれを含有する医薬組成物
JPH08143566A (ja) * 1994-11-25 1996-06-04 Terumo Corp キナゾリン誘導体及びそれを含有する医薬組成物
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3929512B2 (ja) * 1995-06-02 2007-06-13 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法

Also Published As

Publication number Publication date
DE69508029T2 (de) 1999-10-21
DK0708098T3 (da) 1999-10-04
FI954763A7 (fi) 1996-04-08
US5703096A (en) 1997-12-30
HUT72642A (en) 1996-05-28
KR960014124A (ko) 1996-05-22
CA2159938A1 (en) 1996-04-08
CN1143639A (zh) 1997-02-26
KR100250175B1 (ko) 2000-05-01
DE69508029D1 (de) 1999-04-08
NO953990L (no) 1996-04-09
NO305954B1 (no) 1999-08-23
CN1056840C (zh) 2000-09-27
IL115536A0 (en) 1996-01-19
ES2132536T3 (es) 1999-08-16
NO953990D0 (no) 1995-10-06
IL115536A (en) 1999-07-14
AU3307695A (en) 1996-05-02
GR3030207T3 (en) 1999-08-31
TW400329B (en) 2000-08-01
CZ261095A3 (en) 1996-04-17
FI954763A0 (fi) 1995-10-06
AU688573B2 (en) 1998-03-12
HU9502925D0 (en) 1995-11-28
US5972959A (en) 1999-10-26
ATE177088T1 (de) 1999-03-15
NZ280181A (en) 1996-11-26
RU2122998C1 (ru) 1998-12-10
EP0708098B1 (en) 1999-03-03
US5780490A (en) 1998-07-14
HK1011974A1 (en) 1999-07-23
EP0708098A1 (en) 1996-04-24

Similar Documents

Publication Publication Date Title
MX9504261A (es) Derivados de oxima, su preparacion y su uso terapeutico.
CY1111236T1 (el) Ανοσοτροποποιητικες ενωσεις που περιεχουν γαμμα-γλουταμυλο και βητα-ασπαρτυλο τμημα και μεθοδοι με αυτες
MY118498A (en) Lactam derivatives
TW348178B (en) Octacyclodepsipeptides having an action for killing endoparasites in animals
TR199801392T2 (xx) Halojenopirimidinler.
EP1054004A4 (en) NEW PYRIMIDINE-5-CARBOXAMIDE DERIVATIVES
DK0862566T3 (da) 1-(1,2-Disubstitueret piperidinyl)-4-substituerede piperazindeivater
DK0876359T3 (da) (-)-cis-6(S)-phenyl-5(R)- [4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrat
FR15C0027I1 (es)
NO994115L (no) Nye 1,4-diazacykloheptanderivater og deres anvendelse i haaroksydasjonsfargestoffer
DE69813605D1 (de) Benzofuranderivate
TW331558B (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
FI894082A0 (fi) Foerbaettringar i anslutning till polymerfoereningar.
TW350041B (en) Bis-depside tertiary alkyl ester derivatives and chemical positive photoresist material
TW350840B (en) N-acylpiperazine derivative, antibacterial drug and anti-ulcer drug
ES8604959A1 (es) Un compuesto
ES8707716A1 (es) Procedimiento para la obtencion de 1-aril-4-nitropirazoles
TW349085B (en) Hydroxylamine derivatives and fungicides containing the same
MX9605994A (es) Formilaminofenilsulfonilureas, metodos para prepararlos y su uso como herbicidas y reguladores de crecimiento de la plantas.
TR200001871T2 (tr) İmmünmodülatör bileşikler içeren gamma-glutamil ve beta-aspartil ve ilgili yöntemler.
DK0466662T3 (da) 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser
CA2162761A1 (en) Antineoplastic cyclolignan derivatives
TW346483B (en) Benzene derivatives
ATE119523T1 (de) Isochinolinderivate und ihre salze als proteasehemmer.
NO994670L (no) Polymere aminer